StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Cerenome total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cerenome's total debt was $3.59M at Mar 31, 2024. For fiscal 2023 it was $3.98M, down 26.3% from the year before. Over ten years it grew -17.2% a year on average. The highest annual figure on record is $26.29M in fiscal 2013.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$3.98M-26.3%
FY2022Dec 31, 2022$5.39M-18.4%
FY2021Dec 31, 2021$6.61M+4.4%
FY2020Dec 31, 2020$6.34M-42.7%
FY2019Dec 31, 2019$11.06M-22.1%
FY2018Dec 31, 2018$14.20M+4.2%
FY2017Dec 31, 2017$13.62M-22.8%
FY2016Dec 31, 2016$17.64M+5.7%
FY2015Dec 31, 2015$16.68M-34.3%
FY2014Dec 31, 2014$25.40M-3.4%
FY2013Dec 31, 2013$26.29M+15.9%
FY2012Dec 31, 2012$22.69M-7.2%
FY2011Dec 31, 2011$24.45M+24.1%
FY2010Dec 31, 2010$19.71M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024$3.59M-29.0%
Q4 FY2023Dec 31, 2023$3.98M-26.3%
Q3 FY2023Sep 30, 2023$4.35M-23.9%
Q2 FY2023Jun 30, 2023$4.71M-21.9%
Q1 FY2023Mar 31, 2023$5.06M-20.1%
Q4 FY2022Dec 31, 2022$5.39M-18.4%
Q3 FY2022Sep 30, 2022$5.72M-15.3%
Q2 FY2022Jun 30, 2022$6.03M-8.9%
Q1 FY2022Mar 31, 2022$6.33M-2.5%
Q4 FY2021Dec 31, 2021$6.61M+4.4%
Q3 FY2021Sep 30, 2021$6.75M+9.2%
Q2 FY2021Jun 30, 2021$6.62M+9.8%
Q1 FY2021Mar 31, 2021$6.49M-42.0%
Q4 FY2020Dec 31, 2020$6.34M-42.7%
Q3 FY2020Sep 30, 2020$6.18M-43.5%
Q2 FY2020Jun 30, 2020$6.03M-44.3%
Q1 FY2020Mar 31, 2020$11.18M-22.2%
Q4 FY2019Dec 31, 2019$11.06M-22.1%
Q3 FY2019Sep 30, 2019$10.94M-21.9%
Q2 FY2019Jun 30, 2019$10.81M-21.2%
Q1 FY2019Mar 31, 2019$14.37M+5.5%
Q4 FY2018Dec 31, 2018$14.20M+5.2%
Q3 FY2018Sep 30, 2018$14.01M-3.5%
Q1 FY2018Mar 31, 2018$13.73M-14.7%
Q4 FY2017Dec 31, 2017$13.62M-22.8%
Q3 FY2017Sep 30, 2017$13.50M-22.4%
Q2 FY2017Jun 30, 2017$14.52M-15.4%
Q1 FY2017Mar 31, 2017$16.09M–
Q4 FY2016Dec 31, 2016$17.64M–
Q3 FY2016Sep 30, 2016$17.40M–
Q2 FY2016Jun 30, 2016$17.16M–

More Cerenome figures

See a number that looks wrong?